The HIV diagnosis market will reach a value of USD 9.55 billion, propelling at a 9.7% compound annual growth rate, by 2030.

The growth of the industry is mainly credited to the mounting incidence of AIDS, in part, because of the increasing number of blood donations and transfusions across the globe. Additionally, the benefits provided by point-of-care kits and instruments will further boost the growth of the industry.

In recent years, the consumables category held the largest industry share. This is primarily credited to the growing adoption of assays, kits, and reagents for laboratory along with home-based analytical tests. Moreover, the increasing number of initiatives taken by government organizations to tackle the spread of AIDS will boost the growth of this category in the years to come.

In the past few years, the antibody test category, based on type, accounted for the largest HIV diagnosis market share. This is attributed to the growing approvals number for new antibody tests with higher sensitivity and specificity by numerous regulatory authorities across the globe.

Make inquiry before purchasing of this report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=hiv-diagnosis-market

Additionally, the increasing pace of technological advancements and mounting awareness concerning the disease are boosting the requirement for such tests. Moreover, the growing usage of these tests in India, Malaysia, China, and Thailand is driving the growth of this category.

The diagnostic laboratories category, based on end users, will observe the highest growth rate, of over 10% in the years to come. This is credited to the fact that diagnostic laboratories are one of the key end users of these diagnostic instruments and kits. Moreover, in nations where individuals do not have access to portable diagnostic kits, these laboratories are the backbone of the virus detection ecosystem.

In recent years, North America held the largest share. This is mainly attributed to the high occurrence of AIDS and the increasing awareness regarding AIDS.

Moreover, The European HIV diagnosis industry accounted for the second-largest share of over 20%, in recent years. This is mainly because of the existence of key manufacturers of HIV diagnosis products in the region.

The APAC HIV diagnosis industry will observe the highest growth rate, of approximately 10.8%, in the years to come. This is attributed to the low access to antiretroviral therapy, the increasing population of middle-class people with a rising disposable income, and growing government support for AIDS diagnosis and management, in the region.

It is because of the mounting occurrence of AIDS, due to the mounting number of people receiving or donating blood, along with more than a few individuals open to unprotected sex, the global HIV diagnosis industry will continue to advance significantly in the years to come.